Estimated HIV incidence among high-risk heterosexuals in New York city, 2007

Journal of Acquired Immune Deficiency Syndromes

Volumn 56, Issue 2, 2011, Pages 193-197

  Jenness, Samuel M ^a   Neaigus, Alan ^a   Murrill, Christopher S ^a   Wendel, Travis ^b   Forgione, Lisa ^a   Hagan, Holly ^c  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

heterosexual; high risk; HIV; incidence; prevalence

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; FEMALE; HETEROSEXUALITY; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PREVALENCE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; UNITED STATES;

ADOLESCENT; ADULT; FEMALE; HETEROSEXUALITY; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEW YORK CITY; RISK-TAKING; YOUNG ADULT;

EID: 78751628372     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318202a9c4     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention. HIV prevalence estimates-United States, 2006. MMWR Morb Mortal Wkly Rep. 2008;57: 1073-1076.
2. Hall HI, Geduld J, Boulos D, et al. Epidemiology of HIV in the United States and Canada: current status and ongoing challenges. J Acquir Immune Defic Syndr. 2009;51(Suppl 1):S13-S20.
3. Centers for Disease Control and Prevention. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR Recomm Rep. 1999;48(RR-13):1-27, 29-31.
4. Vu MQ, Steketee RW, Valleroy L, et al. HIV incidence in the United States, 1978-1999. J Acquir Immune Defic Syndr. 2002;31:188-201.
5. Hallfors DD, Iritani BJ, Miller WC, et al. Sexual and drug behavior patterns and HIV and STD racial disparities: the need for new directions. Am J Public Health. 2007;97:125-132.
6. El-Sadr WM, Mayer KH, Hodder SL. AIDS in America-forgotten but not gone. N Engl J Med. 2010;362:967-970.
7. Des Jarlais DC, Perlis T, Arasteh K, et al. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health. 2005;95:1439-1444.
8. Taylor MM, Hawkins K, Gonzalez A, et al. Use of the serologic testing algorithm for recent HIV seroconversion (STARHS) to identify recently acquired HIV infections in men with early syphilis in Los Angeles County. J Acquir Immune Defic Syndr. 2005;38:505-508.
9. Gallagher KM, Sullivan PS, Lansky A, et al. Behavioral surveillance among people at risk for HIV infection in the U.S.: the National HIV Behavioral Surveillance System. Public Health Rep. 2007;122(Suppl 1): 32-38. (Pubitemid 47450427)
10. Jenness SM, Murrill CS, Liu KL, et al. Missed opportunities for HIV testing among high-risk heterosexuals. Sex Transm Dis. 2009;36: 704-710.
11. Heckathorn D. Extensions of respondent-driven sampling: analyzing continuous variables and controlling for differential recruitment. Sociological Methodology. 2007;37:151-207.
12. Nash D, Bennani Y, Ramaswamy C, et al. Estimates of HIV incidence among persons testing for HIV using the sensitive/less sensitive enzyme immunoassay, New York City, 2001. J Acquir Immune Defic Syndr. 2005; 39:102-111.
13. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA. 1998;280:42-48.
14. Braunstein SL, van de Wijgert JH, Nash D. HIV incidence in sub-Saharan Africa: a review of available data with implications for surveillance and prevention planning. AIDS Rev. 2009;11:140-156.
15. Barroso PF, Harrison LH, de Fatima Melo M, et al. Identification of a high-risk heterosexual cohort for HIV vaccine efficacy trials in Rio de Janeiro, Brazil, using a sensitive/less-sensitive assay: an update. J Acquir Immune Defic Syndr. 2004;36:880-881.
16. Edlin BR, McCoy CB, Word CO, et al. High HIV incidence among young urban street-recruited crack cocaine smokers [WEC226]. Presented at: International AIDS Conference; July 7, 1996; Vancouver, Canada.
17. Jenness SM, Neaigus A, Hagan H, et al. Heterosexual HIV and sexual partnerships between injection drug users and noninjection drug users. AIDS Patient Care STDS. 2010;24:175-181.
18. Ford K, Sohn W, Lepkowski J. American adolescents: sexual mixing patterns, bridge partners, and concurrency. Sex Transm Dis. 2002;29:13-19.
19. McQuillan GM, Kruszon-Moran D.HIV Infection in the United States Household Population Aged 18-49 Years: Results From 1999-2006. NCHS data brief no 4. Hyattsville, MD: National Center for Health Statistics; 2008.
20. Wiewel EW, Hanna DB, Begier EM, et al. High HIV prevalence and diagnosis rates in New York City black men. J Community Health. 2010; [Epub ahead of print June 24].
21. Denning P, DiNenno E. Communities in crisis: is there a generalized HIV epidemic in impoverished urban areas of the United States? [WEPDD101]. Presented at: International AIDS Conference; July 18 2010; Vienna, Austria.
22. Magnus M, Kuo I, Shelley K, et al. Risk factors driving the emergence of a generalized heterosexual HIV epidemic in Washington, District of Columbia networks at risk. AIDS. 2009;23:1277-1284.
23. Remis RS, Palmer RW. Testing bias in calculating HIV incidence from the serologic testing algorithm for recent HIV seroconversion. AIDS. 2009; 23:493-503.
24. Brookmeyer R. On the statistical accuracy of biomarker assays for HIV incidence. J Acquir Immune Defic Syndr. 2010;54:406-414.
25. NIMH Multisite HIV/STD Prevention Trial for African American Couples Group. Eban health promotion intervention: conceptual basis and procedures. J Acquir Immune Defic Syndr. 2008;49(Suppl 1): S28-S34.